Sanofi lifted its 2018 profit target for the second time this year after robust sales of its vaccines and rare diseases division, Genzyme, helped it beat third-quarter profit expectations.

https://ift.tt/2ERaDms support@endlesssupplies.biz (Endless Supplies .Biz) October 31, 2018 at 04:51AM
No comments:
Post a Comment